Novo Nordisk Articles
Record Number Of New Chemical Entities In 1996
20 January 1997
Novo Nordisk's US Launch Plans For Norditropin
13 January 1997
Novo's Norditropin Cleared In USA
6 January 1997
Novo Nordisk In China
6 January 1997
Alanex/Novo Nordisk Expand Collaboration
23 December 1996
Astra's Losec "World's No One Drug In 1998-2000"
16 December 1996
Novo Nordisk' Health Care Business Sees Best Growth
18 November 1996
Overseas Sales Boost Schering AG's Profit
18 November 1996
Boeh Ingelheim/Novo Nordisk Anti-Obesity Collaboration
18 November 1996
Novo Nordisk Research Deal With Takeda
4 November 1996
Ontogen Signs $18 Million Deal With Novo Nordisk
28 October 1996
Novo Nordisk Cuts Staff And Services
21 October 1996
EUROPEAN STOCK COMMENT
7 October 1996
Genentech Files Against Novo Nordisk On Insulin
7 October 1996
Schering AG and NN To Join In Infertility Treatments
30 September 1996
Preliminary Injunction Against Eli Lilly
9 September 1996
Competition Concerns For Novo Nordisk
9 September 1996
Novo Nordisk Gets License From Scios For Insulinotropin
9 September 1996
Novo Nordisk's Gabitril: Thinking Beyond Partial Seizure Control
9 September 1996
Novo Nordisk On Target For 1996
19 August 1996
Novo Nordisk Files Suit Against Eli Lilly
12 August 1996
Novo Nordisk In Disease Management Partnership
8 July 1996
UK Industry Code of Practice Review
8 July 1996
Novo Nordisk Rationalizing
24 June 1996
UK, Danish Launch For Novo's NovoSeven
24 June 1996
First Approval For Novo Nordisk's Tiagabine
24 June 1996
Plasma Plans
20 May 1996
Profits Rise At Novo Nordisk In 1st Qtr
20 May 1996
R-PR And Novo Forge HRT Alliance
20 May 1996
Are Drug Firms Providing Shareholder Value?
20 May 1996
HemaSure Buys Novo Nordisk Unit
13 May 1996
Novo Nordisk, Alanex Link-Up
29 April 1996
China Denies Block On Drug Investment
22 April 1996
Novo Raises Diabetes Commitment
15 April 1996
What Future For Biotechnology At AHP?
15 April 1996
EMEA Approves Novo Nordisk's NovoSeven
25 March 1996
EMEA Approves Novo Nordisk's NovoSeven
25 March 1996
Currency Impact Hits Novo Nordisk
18 March 1996
Growth Hormone Dispute Rolls On
4 March 1996
Sweden's Pharma Market Expanded 12.7% In 1995
4 March 1996
First NovoSeven Approval
26 February 1996
Novo Nordisk Deal
26 February 1996
Losec "Will Be The World's Top-Selling Drug In 2000"
26 February 1996
Novo Nordisk Will Not Cut Insulin Prices
19 February 1996
Novo Nordisk And HemaSure Make Plasma Deal
12 February 1996
Novo Nordisk / Bio-Intermediair deal for antibodies
22 January 1996
Management changes at Novo Nordisk
8 January 1996
Novo Nordisk's Seoxat: news and more news
4 December 1995
Anergen Immune Therapy For Diabetes
27 November 1995
B Mannheim In Deal With Novo Nordisk
20 November 1995
Strong 9 Months Earnings Growth For Novo Nordisk
20 November 1995
Novo Nord sells Ferrosan
13 November 1995
Swedish Pharma Market Jan-Sept 1995
6 November 1995
Novo Nordisk to Abbott business transfer
30 October 1995
Yamanouchi Looks To New Products For Growth
23 October 1995
Novo Nordisk Admits Ferrosan Disposal Talks In Progress
2 October 1995
$200M Investment For Novo Nordisk In China
25 September 1995
Strong Sales Growth For Biotechnology General
11 September 1995
Promising Efficacy And Safety Results For Tiagabine
4 September 1995
Incyte Signs Database Deal With Novo Nordisk
4 September 1995
European stock comment
21 August 1995
Novo Nordisk/Amgen/Kirin thrombopoietin venture
21 August 1995
Novo Nordisk's First Half
14 August 1995
European Drug Sector Still Undervalued, Says Broker
31 July 1995
Genentech Granted Stop On Sales Of Norditropin
3 July 1995
Amylin Restructures Its Diabetes Collaborations
26 June 1995
Good Performance Forecast For Euro Drugmakers
26 June 1995
Novo Nordisk promotes three
5 June 1995
Good First Quarter For Novo Nordisk
15 May 1995
Chinese JV For Novo Nordisk
17 April 1995
Novo Details New Contraceptive Modality
17 April 1995
Kliofem Available In The UK
20 March 1995
Novo Nordisk Reports Strong Sales In 1994
13 March 1995
Novo Nordisk Backs Scottish Biotech Firm
6 February 1995
Genentech's ITC Complaint Dismissed
23 January 1995
Novo Nordisk Divests Anticoagulants
23 January 1995
Novo Nordisk Defines Future Strategy
9 January 1995
Promising Data With Thrombopoietin
12 December 1994
Genentech Setback In hGH Suit
12 December 1994
Novo Nordisk And Connaught Replace JV
21 November 1994
Disappointing 9-Month Results at Novo Nordisk
14 November 1994
Gist-Broc/Novo Deal
7 November 1994
Novo Nordisk Appointment
31 October 1994
China - Novo Nordisk
31 October 1994
Change Is An Opportunity, SB Chief Tells IFPMA
19 September 1994
Novo Nordisk Depressed In 1st Half
15 August 1994
Algerian/Danish Pharma Firms Deal
15 August 1994
Novo Nordisk To Build Pharma Plant In Japan
1 August 1994
NEW YORK STOCK COMMENT
27 June 1994
BIOPHARMA GROWTH MARKETS OF THE FUTURE
27 June 1994
THROMBOPOIETIN CLONED IN MAJOR BREAKTHROUGH
20 June 1994
ANIMAL INSULIN
20 June 1994
BIOPHARMACEUTICALS MARKET GROWING FAST
13 June 1994
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
